Skip to main content
BMC Medical Co., Ltd. logo

BMC Medical Co., Ltd. — Investor Relations & Filings

Ticker · 301367 ISIN · CNE100005WQ4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 528 across all filing types
Latest filing 2025-08-27 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 301367

About BMC Medical Co., Ltd.

https://www.bmc-medical.com

BMC Medical Co., Ltd. specializes in the development and distribution of diagnostic and therapeutic solutions for sleep-disordered breathing and chronic respiratory conditions. The company’s core product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) systems, and high-flow oxygen therapy equipment. These are complemented by a range of patient interfaces, including nasal, pillow, and full-face masks. BMC integrates digital health capabilities through cloud-based management platforms, enabling remote data analysis and patient monitoring. By focusing on technical innovation and clinical efficacy, the company provides integrated respiratory care systems designed to improve patient compliance and therapeutic outcomes for conditions such as obstructive sleep apnea and chronic obstructive pulmonary disease.

Recent filings

Filing Released Lang Actions
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2025 年半年度报告' which translates to '2025 Semi-Annual Report'. It contains detailed financial data such as revenue, net profit, earnings per share, and cash flow for the half-year period ending June 30, 2025. It also includes management discussion and analysis, company overview, product descriptions, and other comprehensive financial and operational information. The length is substantial (15,000 characters), and it contains actual financial statements and substantive analysis, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-27 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Beijing Ruimait Medical Technology Co., Ltd. It details the convening and decisions made at the 15th meeting of the 3rd board, including approval of the 2025 semi-annual report and other corporate governance matters. The text references that the full semi-annual report and other detailed disclosures are published separately on the CNINFO website, indicating this document itself is not the report but an announcement of board resolutions. The document length is short (2162 characters) and primarily serves to announce board decisions rather than provide full financial data or detailed report content. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and governance decisions.
2025-08-27 Chinese
关于召开2025年第二次临时股东会的通知
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed notice about convening the 2025 second extraordinary general meeting of shareholders for Beijing Ruimait Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures, agenda items, registration details, and proxy forms. There is no financial data, earnings information, or audit content. It is not a report but a formal announcement and invitation to shareholders to attend and vote at the meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA) or a Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting itself and voting procedures rather than solicitation materials or proxy statements, it best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) as it relates to shareholder voting rights and meeting arrangements. Confidence is high due to the detailed meeting and voting information provided.
2025-08-27 Chinese
关于新增公司2025年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the addition of expected daily related-party transactions for the fiscal year 2025 by Beijing Ruimait Medical Technology Co., Ltd. It details the nature, amounts, and approvals of these related-party transactions, including board and independent director approvals, but does not contain financial statements or comprehensive financial data. It is a regulatory announcement about related-party transactions, which is a typical regulatory filing to inform shareholders and the market about such transactions. The document is not an annual or interim report, audit report, or earnings release. It is not a voting result or management change announcement. It fits best under Regulatory Filings (RNS) as it is a compliance disclosure about related-party transactions.
2025-08-27 Chinese
信息披露暂缓与豁免制度
Governance Information Classification · 95% confidence The document is a detailed internal policy of Beijing Ruimait Medical Technology Co., Ltd. regarding the procedures and rules for delaying or exempting information disclosure. It references relevant laws and regulations, outlines internal processes, responsibilities, and confidentiality requirements related to information disclosure. There are no financial statements, earnings data, or investor presentations. It is not an announcement of a report but a governance-related internal regulation document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices.
2025-08-27 Chinese
外汇套期保值业务管理制度
Governance Information Classification · 95% confidence The document is titled '外汇套期保值业务管理制度' which translates to 'Foreign Exchange Hedging Business Management System' and contains detailed internal policies, procedures, and governance related to the company's foreign exchange hedging activities. It includes chapters on general principles, operational rules, approval authority, management and internal processes, information isolation, risk management, information disclosure, and archival management. There is no indication that this is a financial report, earnings release, or regulatory filing announcing a report. It is a governance document outlining internal rules and controls. Therefore, the document best fits the category of Governance Information (CGR). The document length is 3173 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification. Hence, it is not an RPA or RNS filing.
2025-08-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.